CorMedix to buy Deerfield-backed Melinta Therapeutics

Melinta is a commercial-stage company providing therapies for acute and life-threatening illnesses.

8 August 2025•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.